Home › ABRAXANE Now Reimbursed in Italy as a First-Line Treatment of Adult...
 

Keywords :   


ABRAXANE Now Reimbursed in Italy as a First-Line Treatment of Adult...

2015-02-24 18:17:35| Biotech - Topix.net

Celgene International SA rl, a wholly owned subsidiary of Celgene Corporation , today announced that Italian authorities have issued a positive decision for NHS reimbursement of ABRAXANEA in combination with gemcitabine, for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, or pancreatic cancer. For the first time in this disease, the Italian Medicines Agency has recognised the important innovation that ABRAXANE brings as a therapeutic treatment for pancreatic cancer.

Tags: of treatment italy adult

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »